Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Oral semaglutide
DRUG: Empagliflozin 10 mg

Sponsor

University Medical Centre Ljubljana